American Financial Advisors LLC Has $246,000 Stock Holdings in Aflac Incorporated (NYSE:AFL)

American Financial Advisors LLC grew its position in Aflac Incorporated (NYSE:AFL) by 6.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,985 shares of the financial services provider’s stock after purchasing an additional 182 shares during the period. American Financial Advisors LLC’s holdings in Aflac were worth $246,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. BKM Wealth Management LLC bought a new position in Aflac during the fourth quarter valued at about $1,558,000. Nordea Investment Management AB grew its position in Aflac by 25.9% during the fourth quarter. Nordea Investment Management AB now owns 1,693,249 shares of the financial services provider’s stock valued at $139,676,000 after buying an additional 348,400 shares during the period. G&S Capital LLC grew its position in Aflac by 65.1% during the fourth quarter. G&S Capital LLC now owns 31,825 shares of the financial services provider’s stock valued at $2,626,000 after buying an additional 12,551 shares during the period. DekaBank Deutsche Girozentrale grew its position in Aflac by 7.5% during the fourth quarter. DekaBank Deutsche Girozentrale now owns 376,087 shares of the financial services provider’s stock valued at $30,786,000 after buying an additional 26,338 shares during the period. Finally, Kestra Private Wealth Services LLC grew its position in Aflac by 12.7% during the third quarter. Kestra Private Wealth Services LLC now owns 48,745 shares of the financial services provider’s stock valued at $3,741,000 after buying an additional 5,477 shares during the period. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on AFL shares. Piper Sandler increased their price target on shares of Aflac from $90.00 to $95.00 and gave the company an “overweight” rating in a research report on Friday, April 5th. Raymond James increased their target price on shares of Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a research report on Friday, February 2nd. UBS Group increased their target price on shares of Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 10th. StockNews.com lowered shares of Aflac from a “hold” rating to a “sell” rating in a research report on Wednesday, April 10th. Finally, Wells Fargo & Company cut their target price on shares of Aflac from $83.00 to $81.00 and set an “equal weight” rating for the company in a research report on Thursday, April 11th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, Aflac currently has an average rating of “Hold” and an average price target of $82.15.

Insider Activity at Aflac

In related news, Director Masatoshi Koide sold 30,493 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $79.91, for a total value of $2,436,695.63. Following the sale, the director now directly owns 86,090 shares of the company’s stock, valued at $6,879,451.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Aflac news, Director Masatoshi Koide sold 30,493 shares of Aflac stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the transaction, the director now directly owns 86,090 shares of the company’s stock, valued at $6,879,451.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Albert Riggieri sold 8,000 shares of Aflac stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $83.34, for a total transaction of $666,720.00. Following the transaction, the senior vice president now directly owns 32,825 shares in the company, valued at $2,735,635.50. The disclosure for this sale can be found here. Insiders have sold 46,493 shares of company stock valued at $3,765,706 over the last three months. 0.90% of the stock is owned by corporate insiders.

Aflac Price Performance

Shares of AFL stock traded up $2.25 during trading hours on Friday, reaching $83.23. The stock had a trading volume of 6,325,052 shares, compared to its average volume of 2,295,166. The stock’s fifty day simple moving average is $82.11 and its 200 day simple moving average is $81.46. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.33. Aflac Incorporated has a 12 month low of $64.10 and a 12 month high of $86.26. The firm has a market capitalization of $47.89 billion, a PE ratio of 10.74, a PEG ratio of 2.20 and a beta of 0.91.

Aflac (NYSE:AFL) last announced its earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). The company had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $4.44 billion. Aflac had a net margin of 24.92% and a return on equity of 17.59%. During the same period in the prior year, the business earned $1.29 earnings per share. On average, equities research analysts predict that Aflac Incorporated will post 6.41 EPS for the current year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.